Rituximab (Rituxan) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard induction therapy for patients with advanced-stage diffuse large B-cell lymphoma, including both elderly and younger patients.
Jerry Ingram
Advertisement
Articles by Jerry Ingram
For clinicians, MRI may offer a more in-depth view than mammography for planning surgery and screening for contralateral breast cancers, but does use of MRI actually benefit patients?
Advertisement
Latest Updated Articles
- R-CHOP is standard of care for advanced DLBCL patients
Published: November 1st 2007 | Updated: March 11th 2024
- Preop MRI for breast cancer: Intuition no substitute for data
Published: November 1st 2007 | Updated: November 10th 2020
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Accelerated Approval to Zongertinib in HER2+ NSCLC
2
Iza-Bren Yields Statistically Significant Efficacy in Advanced TNBC
3
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
4
Decoding Key Community Oncology Takeaways From ASCO GI 2026
5